Choosing between a Vice President of Quality and a Chief Quality Officer (CQO) is an important organizational decision for companies operating in regulated manufacturing and other quality-critical industries. Both roles can provide senior oversight of quality systems, compliance, product reliability, and continuous improvement. The difference lies less in the title itself and more in the […]
Author Archives: Jeremy Gleason
The molecular diagnostics and precision medicine sectors represent one of the most dynamic, high-impact frontiers in modern healthcare. Driven by breakthroughs in next-generation sequencing (NGS), quantitative PCR (qPCR), multiplex panels, and oncology liquid biopsies, diagnostic tools have evolved from simple laboratory tests into foundational pillars of clinical decision-making. However, taking a molecular assay from a […]
As a technology-driven enterprise scales, its intellectual property portfolio evolves from a scattered collection of early invention disclosures into a massive, mission-critical corporate asset. Patents, trade secrets, and proprietary technologies become the primary shields against aggressive competitors and the foundational anchors of corporate valuation during fundraising, joint ventures, or M&A exits. However, when an organization […]
Hiring a quality assurance executive is a strategic decision for manufacturers operating in regulated environments. The right leader helps establish effective quality systems, strengthen compliance, reduce operational risk, and ensure that products consistently meet defined requirements. Organizations working with quality assurance executive recruiters can focus their search on candidates who combine technical quality expertise with […]
Hiring a Chief Human Resources Officer (CHRO) is a strategic decision that can influence organizational performance, leadership effectiveness, workforce productivity, and long-term growth. The right executive does more than oversee recruitment, compensation, and employee relations. A high-performing CHRO connects the organization’s people strategy with its commercial objectives, ensuring that the business has the leadership capabilities, […]
In today’s knowledge-based economy, a company’s intellectual property (IP) is often its most valuable asset. Whether in deep tech, biotechnology, pharmaceuticals, software, or advanced manufacturing, patents, trade secrets, trademarks, and copyrights represent the foundational moat that protects market share, deters competitors, and drives corporate valuation. Yet, a massive disconnect frequently plagues corporate boardrooms: intellectual property […]
In the highly regulated medical device, pharmaceutical, and life sciences sectors, executive organizational design is a critical determinant of commercial success and regulatory compliance. As companies scale their product portfolios and expand into global markets, boards and CEOs frequently encounter a foundational structural question: Should Regulatory Affairs and Quality Assurance report to a single unified […]
Hiring senior leaders in in vitro diagnostics (IVD) requires a clear understanding of how quality systems, manufacturing performance, and market access influence one another. Diagnostic companies need executives who can protect product reliability while expanding production capacity, supporting regulatory compliance, and building commercially sustainable operations. Organizations working with in vitro diagnostics executive recruiters can focus […]
The global Agricultural Technology (AgTech) sector has matured past its initial phase of unbridled venture capital exuberance. Over the past decade, investors poured billions of dollars into precision agriculture, autonomous field robotics, IoT sensor networks, and advanced farm management software (FMS). These investments successfully funded brilliant scientific and engineering breakthroughs. However, the industry has now […]
In today’s highly regulated medical device, pharmaceutical, and life sciences sectors, regulatory compliance is no longer a back-office administrative function—it is a core strategic pillar of enterprise value. Bringing a complex product to market requires navigating a labyrinth of global regulatory frameworks, including the FDA in the United States, the EU MDR/IVDR in Europe, and […]










